Skip to content

Clinical trials

Completed Phase 1/2 Hematologic Neoplasms trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hematologic Neoplasms Phase: Phase 1/2 Status: Completed Clear all

53 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20024
20031
20042
20052
20067
20072
20082
20094
20106
20112
20123
20133
20142
20152
20162
20171
20181
20191
20213
20231
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed53

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)3
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University3
Assistance Publique - Hôpitaux de Paris2
Dana-Farber Cancer Institute2
Gamida Cell ltd2
M.D. Anderson Cancer Center2
Novartis Pharmaceuticals2
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins2
AGC Biologics S.p.A.1
Accenture1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hematologic Neoplasms53
Myelodysplastic Syndromes13
Leukemia11
Leukemia, Myeloid, Acute11
Precursor Cell Lymphoblastic Leukemia-Lymphoma10
Lymphoma, Non-Hodgkin9
Multiple Myeloma9
Leukemia, Myelogenous, Chronic, BCR-ABL Positive8
Lymphoma8
Hodgkin Disease7

Trials

Showing 1 to 25 of 53. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.